Tower Research Capital (TRC)’s Allied Healthcare Products AHPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,454
| Closed | – | – | 6651 |
|
|
2023
Q1 | $0 | Buy |
12,454
+6,816
| +121% | +$6.38K | ﹤0.01% | 6711 |
|
|
2022
Q4 | $5K | Buy |
5,638
+3,276
| +139% | +$3.86K | ﹤0.01% | 4955 |
|
|
2022
Q3 | $3K | Buy |
+2,362
| New | +$4.34K | ﹤0.01% | 5487 |
|
|
2022
Q2 | – | Sell |
-1,228
| Closed | -$4K | – | 6881 |
|
|
2022
Q1 | $4K | Buy |
+1,228
| New | +$4.33K | ﹤0.01% | 5318 |
|
|
2021
Q2 | – | Sell |
-177
| Closed | -$1K | – | 6064 |
|
|
2021
Q1 | $1K | Buy |
+177
| New | +$1.01K | ﹤0.01% | 5264 |
|
|
2020
Q4 | – | Sell |
-619
| Closed | -$3K | – | 5510 |
|
|
2020
Q3 | $3K | Buy |
+619
| New | +$5.24K | ﹤0.01% | 4544 |
|
|
2020
Q1 | – | Sell |
-688
| Closed | -$1K | – | 4200 |
|
|
2019
Q4 | $1K | Buy |
688
+278
| +68% | +$320 | ﹤0.01% | 3370 |
|
|
2019
Q3 | $1K | Buy |
410
+253
| +161% | +$387 | ﹤0.01% | 3970 |
|
|
2019
Q2 | $0 | Sell |
157
-2,281
| -94% | -$4.01K | ﹤0.01% | 4515 |
|
|
2019
Q1 | $4K | Sell |
2,438
-956
| -28% | -$1.78K | ﹤0.01% | 3228 |
|
|
2018
Q4 | $6K | Sell |
3,394
-814
| -19% | -$1.65K | ﹤0.01% | 2840 |
|
|
2018
Q3 | $9K | Buy |
4,208
+693
| +20% | +$1.67K | ﹤0.01% | 2854 |
|
|
2018
Q2 | $8K | Buy |
+3,515
| New | +$8.96K | ﹤0.01% | 2905 |
|
|
2017
Q4 | – | Sell |
-4,573
| Closed | -$10K | – | 4198 |
|
|
2017
Q3 | $10K | Sell |
4,573
-697
| -13% | -$1.56K | ﹤0.01% | 3086 |
|
|
2017
Q2 | $15K | Buy |
+5,270
| New | +$10.8K | ﹤0.01% | 1388 |
|
|
2017
Q1 | – | Sell |
-600
| Closed | -$1K | – | 4152 |
|
|
2016
Q4 | $1K | Buy |
+600
| New | +$1.34K | ﹤0.01% | 3691 |
|
|
2016
Q3 | – | Sell |
-663
| Closed | -$1K | – | 4705 |
|
|
2016
Q2 | $1K | Sell |
663
-150
| -18% | -$190 | ﹤0.01% | 4258 |
|
|
2016
Q1 | $1K | Sell |
813
-249
| -23% | -$395 | ﹤0.01% | 3854 |
|
|
2015
Q4 | $2K | Sell |
1,062
-1,548
| -59% | -$3.71K | ﹤0.01% | 3855 |
|
|
2015
Q3 | $6K | Sell |
2,610
-506
| -16% | -$1.48K | ﹤0.01% | 2709 |
|
|
2015
Q2 | $10K | Buy |
3,116
+2,483
| +392% | +$7.56K | ﹤0.01% | 2728 |
|
|
2015
Q1 | $2K | Buy |
633
+627
| +10,450% | +$2.01K | ﹤0.01% | 3865 |
|
|
2014
Q4 | $0 | Sell |
6
-2,432
| -100% | -$8.73K | ﹤0.01% | 4889 |
|
|
2014
Q3 | $10K | Buy |
2,438
+1,966
| +417% | +$8.45K | ﹤0.01% | 2844 |
|
|
2014
Q2 | $2K | Sell |
472
-53
| -10% | -$241 | ﹤0.01% | 3493 |
|
|
2014
Q1 | $2K | Sell |
525
-288
| -35% | -$1.36K | ﹤0.01% | 3941 |
|
|
2013
Q4 | $4K | Buy |
+813
| New | +$3.75K | ﹤0.01% | 3722 |
|
Tower Research Capital (TRC)'s AHPI Position: Q2 2023 in Review
Tower Research Capital (TRC) sold out of Allied Healthcare Products (AHPI) in Q2 2023, closing a stake of 12,454 shares.
Tower Research Capital (TRC) first reported a position in AHPI in Q4 2013 and held it in 27 quarters. The position peaked at $15K in Q2 2017. 0 funds tracked by Wall St. Rank hold AHPI as of Q2 2023.
- Tower Research Capital (TRC) reported no remaining Allied Healthcare Products position as of Q2 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 12,454 Allied Healthcare Products shares in Q2 2023.
- Tower Research Capital (TRC) first reported a position in Allied Healthcare Products in Q4 2013 and held it in 27 quarters.
- Tower Research Capital (TRC)'s Allied Healthcare Products position peaked at $15K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q2 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.